Active substances
Dimethindene + Phenylephrine
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| VIBROCIL NASAL DROPS | 0.25,2.5 mg/ml,mg/ml | Nasal drops, solution · Nasal use | 1 Dropper Container | SAR 11.40 | NCE · OTC | GSK CONSUMER HEALTHCARE SCHWEIZ AG | Withdrawn by MAH · Not Marketed |
| VIBROCIL NASAL GEL | 0.25 , 2.5 g | Nasal gel · Nasal use | 1 Tube | SAR 11.40 | NCE · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
| VIBROCIL SPRAY MICRODOSEUR | 0.25,2.5 mg/ml,mg/ml | Spray · Nasal use | 1 Spray Container | SAR 11.40 | NCE · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.